Skip to main content

RT @ericdeinmd: L05 #ACR22 High-dose Denosumab in Erosive Hand OA 48Wk, Double-blind PBO Phase 2 100 patients GUSS chang

Nov 14, 2022 10:44 am
Social Author Name
Eric Dein
Tweet Content
L05 #ACR22 High-dose Denosumab in Erosive Hand OA 48Wk, Double-blind PBO Phase 2 100 patients GUSS change higher in DEN v PBO at w24, incr at w48 New erosions lower in DEN w48 (2% v 7%, OR 0.23, p<0.001) Open label extension w improvement to baseline @RheumNow https://t.co/X6MF9q2bKj
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×